Mark Coleman, Director: Axsome Therapeutics AXSM Sell · Filed 25/05/29

Trade details

Type: Insider sale
Amount: $395,512.5
Shares · price: 3,750 sh · $105.47 a share
Held after: 50,387 sh
Stock: Axsome Therapeutics AXSM
Person: Mark ColemanDirector
Trade date: 25/05/27
Filed: 25/05/29
Days to filing: 2 days

Sold 6.9% of holdings

Share of holding sold: 6.9%

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/27~25/06/26

Mark Coleman's recent trades

Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$160.1K
643 sh
$160.1K
Filed 06/10
Traded 06/10
Mark ColemanDirector
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$160.1K
643 sh
$160.1K
Filed 06/10
Traded 06/10
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
6,000 sh
$1.4M
Filed 06/02
Traded 05/29
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
6,000 sh
$1.4M
Filed 06/02
Traded 06/01
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.2M
5,537 sh
$1.2M
Filed 06/02
Traded 06/02